Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle
Open Access
- 21 December 2010
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 11 (12), 5323-5338
- https://doi.org/10.3390/ijms11125323
Abstract
Naturally occurring cucurbitacins have been shown to have anticancer, antimicrobial and anti-inflammatory activities. In this study, we determined the effects of cucurbitacin B extracted from the Thai herb Trichosanthes cucumerina L. on telomerase regulation in three human breast cancer cell lines (T47D, SKBR-3, and MCF-7) and a mammary epithelium cell line (HBL-100). Cell viability after treatment with cucurbitacin B, which is an active ingredient of this herb, was assessed. Telomeric Repeat Amplification Protocol (TRAP) assays and RT-PCR (qualitative and realtime) were performed to investigate activity of telomerase as well as expression of human telomerase reverse transcriptase (hTERT) and c-Myc. The c-Myc protein level was also determined in SKBR-3 and HBL-100 cells. Our results show that the cucurbitacin B inhibits growth and telomerase activity in the three breast cancer cell lines and exerts an obvious inhibitory effect in the estrogen receptor (ER)-negative breast cancer SKBR-3 cells. The expression of hTERT and c-Myc were also inhibited by cucurbitacin B, In addition, a clear reduction of c-Myc protein was observed after treatment in SKBR-3 cells even with a concentration of cucurbitacin B that was ten-times lower compared to the concentration used for HBL-100. Our findings imply that cucurbitacin B exerts an anticancer effect by inhibiting telomerase via down regulating both the hTERT and c-Myc expression in breast cancer cells.Keywords
This publication has 41 references indexed in Scilit:
- Natural products in drug discoveryDrug Discovery Today, 2008
- Breast Cancer in 2007: Incidence, Risk Assessment, and Risk Reduction StrategiesClinical Journal of Oncology Nursing, 2007
- Telomeres and telomerase in cancer stem cellsEuropean Journal Of Cancer, 2006
- Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cellsLife Sciences, 2006
- Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cellsCancer Letters, 2005
- Telomerase in Breast CancerAdvances in Anatomic Pathology, 2004
- The role of telomerase in breast cancerEuropean Journal of Surgical Oncology, 2000
- Using a non-radioisotopic, quantitative TRAP-based method detecting telomerase activities in human hepatoma cellsCell Research, 2000
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- Transcriptional regulation by MAP kinasesMolecular Reproduction and Development, 1995